NCT00696631 - European Trial of Dronedarone in Moderate to Severe Congestive Heart Failure | Biotech Hunter

Enrollment

653

Participants

Timeline

Start Date

June 30, 2002

Primary Completion Date

January 31, 2003

Study Completion Date

August 31, 2003

Conditions

Congestive Heart Failure

Interventions

DRUG

Dronedarone (SR33589)

oral administration

DRUG

Placebo

oral administration

Trial Locations (6)

Sanofi-aventis Administrative Office, Hørsholm

Sanofi-aventis Administrative Office, Budapest

Sanofi-aventis Administrative Office, Gouda

Sanofi-aventis Administrative Office, Lysaker

Sanofi-aventis Administrative Office, Warsaw

Sanofi-aventis Administrative Office, Bromma